In terms of the mechanisms accounting for neutropenia in CD8+/CD16+/CD56- phenotypic subset characterized by STAT3 mutations, our data suggest a pathogenetic link between STAT3 activation and the development of neutropenia. Here, CD8A is linked to neutropenia.